Celgene and Forma Therapeutics are expanding their already extensive relationship. The Summit, NJ-based drugmaker has exercised a $195 million option to widen the breadth of the 2014 deal it signed with Forma to co-develop drugs for cancer and other therapeutic areas—an agreement that gave Celgene (NASDAQ: CELG) the option to buy Forma down the road. […]
NYS Entity Status
NYS Filing Date
JANUARY 30, 2014
NYS DOS ID#
NYS Entity Type
FOREIGN LIMITED LIABILITY COMPANY
2014 - L&L 195 BROADWAY DEVELOPMENT MANAGER LLC
Around the Web
- Celgene Broadens Forma Deal, Adding $195M More for Drug R&D
By Frank Vinluan - Tuesday Aug 29, 2017
- Cast named for Broadway’s ‘Harry Potter’ show
By Variety - Wednesday Aug 2, 2017
Seven members of the West End company of the play will open the Broadway production next April.
- Lauren Ambrose could be Broadway’s next Eliza Doolittle
By Ian Mohr - Wednesday Aug 23, 2017
Broadway sources are buzzing that Lauren Ambrose is being cast as Eliza Doolittle in the revival of “My Fair Lady.”
- Jason Mraz is heading to Broadway
By Associated Press - Thursday Sep 28, 2017
The "I'm Yours" singer will make his Broadway debut starting Nov. 3.
- The Top 10 Moments of New York Fashion Week
By THE NEW YORK TIMES - Friday Sep 15, 2017
Highlights from the shows, including a celebrity-packed front row at Calvin Klein and a trek to Bedford Hills, N.Y., to see Ralph Lauren’s vintage cars.